Applications of Nanobiotechnology for Neglected Tropical Diseases

Fabio Rocha Formiga graduated in pharmaceutical sciences, obtaining his bachelor’s degree in 2004 from the Federal University of Rio Grande do Norte, Brazil, where he also concluded a master’s course in health sciences. In 2011, he obtained a PhD in pharmaceutical technology from the University of Navarra in Spain, with distinctions, as a MAEC-AECID scholar. In 2018, he completed a research training in nanobiomaterials at the Rice University (Houston, United States). Dr. Formiga has worked as a visiting professor at the University of Coimbra, Portugal. He has experience in teaching/supervision at the BSc, MSc, and PhD levels. In addition, he has acted as referee for national and foreign funding agencies. He has participated as a member of university committees, examination boards, and has organized scientific meetings, including the 22nd International Symposium on Microencapsulation (Chair). Dr. Formiga has also been strongly involved in collaborative programs for exchange with European universities (from Portugal, Spain, and Denmark). He is a cofounder and vice-president of the Brazilian Chapter of Controlled Release Society (CRS, 2019–present) and guest associate editor of the Drug Delivery and Translational Research (Springer) and Pharmaceutical Nanotechnology (Bentham). He is a member of the Brazilian Association of Pharmaceutical Sciences (ABCF) and the European Foundation for Clinical Nanomedicine (CLINAM). Currently, Dr. Formiga is a research scientist and deputy head of the Department of Immunology at the Aggeu Magalhães Institute, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. He also holds a tenured adjunct professor position at University of Pernambuco (UPE). Dr. Formiga was acknowledged with the Research Award from Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG) in 2013 and the Benjamin Gilbert Award from FIOCRUZ in 2017. His research has focused on pharmaceutics, drug delivery, nanotechnology, and biomaterials toward neglected tropical diseases and regenerative medicine.

Dr. Severino is currently working as a professor in the College of Pharmacy and Postgraduate Program in Industrial Biotechnology, Tiradentes University (UNIT), Aracaju, Brazil and is also a research coordinator of Nanomedicine and Nanotechnology Laboratory Institute of Technology and Research (ITP), Aracaju, Brazil. She graduated in pharmacy from the Methodist University of Piracicaba—Unimep (2005). She earned master’s and PhD from the Faculty of Chemical Engineering at the State University of Campinas—Unicamp (2008 and 2012). In the master's she carried out a sandwich program at the Faculty of Pharmacy of the Federal University of Rio Grande do Sul—UFRGS (2007–08), and in her PhD carried out a sandwich program at the Faculty of Pharmacy of the Fernando Pessoa University—UFP, Porto, Portugal (2010–11). She has extensive research experience in multidisciplinary fields of nanomedicine, biomaterial, drug delivery, cosmetics, and biotechnology. She has published about 110 research articles in various international scientific journals, 24 book chapters, and 16 patents. She is a member of editorial boards of variousjournals. She has worked in technical-scientific collaboration with researchers from different institutions in the country and abroad, such as the United States, England, the Czech Republic, EUA, Italy, Turkey, India, and Portugal. She is a CNPq research productivity scholar (PQ-2). Currently, she is working in the internationalization process of UNIT at the Tiradentes Institute (TI-UMass) and is a visiting professor at Brigham and Women’s Hospital/Harvard Medical School, Cambridge, Massachusetts, United States.